Edwards Lifesciences receives FDA approvals for PASCAL and EVOQUE systems

Edwards Lifesciences announced it received US FDA approvals for its PASCAL and EVOQUE systems. The company's EVOQUE system also received regulatory approval for transjugular access in both the United States and Europe.

Detected & updated continuously · Source: Nebula

Story subjects

Edwards Lifesciences CorpFood and Drug Administration

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula